Small DNA Molecules - Evolutionary Catalyst for Antibiotic Resistance

Small DNA molecules known as plasmids are one of the key culprits in spreading the major global health threat of antibiotic resistance.

Antibiotic resistance will lead to 10 million deaths per year by 2050, surpassing cancer as a source of human mortality, predicts an influential report from the O'Neill Commission.

Small DNA molecules known as plasmids are one of the key culprits in spreading the major global health threat of antibiotic resistance, revealed a new study led by scientists at the University of Oxford.

Drug Resistance – Antibiotic or Antimicrobial Resistance
Drug resistance is often a problem in malaria, tuberculosis, HIV, sexually transmitted diseases and hospital acquired diseases. Judicious use of antibiotics can control the problem.

Using a novel experimental model, the international team of researchers show that plasmids, which live inside bacteria and are known to be a vehicle for transferring antibiotic resistance genes, can accelerate the evolution of new forms of resistance - making them more important to the process than previously thought.

The study is published in the journal Nature Ecology and Evolution.

Senior author Professor Craig MacLean, a Wellcome Trust Research Fellow in Oxford's Department of Zoology, said, "The discovery of antibiotics revolutionized medicine by making it much simpler to treat bacterial infections, and this had a big impact on human health and longevity. For example, the use of penicillin led to a 90% decrease in mortality caused by some forms of pneumonia. Unfortunately, few new antibiotics have been discovered over the last 30 years, and resistance to existing antibiotics has spread steadily because antibiotics are used heavily in medicine. This is leading to a crisis in medicine, as we have lost the ability to treat bacterial infections that can have life-threatening consequences."

New Research Speculates On The Rosetta Stone for Antibiotic Resistance
A novel technique to confront the problem of antibiotic resistance is published in JoVE, the Journal of Visualized Experiments.

Professor MacLean said, "The spread of resistance genes in bacterial populations is driven by simple, Darwinian selection: during antibiotic treatment, bacteria with resistance genes have a higher reproductive rate than sensitive bacteria, and, as a result, the use of antibiotics causes the spread of resistance genes."

"Many of the most important resistance genes are found on plasmids, which are small, circular DNA molecules that live inside bacteria. Plasmids are capable of moving between bacteria and are usually thought of as being important "vehicles" that transfer resistance genes between bacteria."

In MRSA, Receptor Proteins may Hold Clues to Antibiotic Resistance
At Imperial College London, scientists have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA.

"Our paper demonstrates that plasmids can also act as evolutionary catalysts that accelerate the evolution of new forms of resistance. This occurs because bacteria usually carry more than one copy of a plasmid, which allows resistance genes carried by plasmids to rapidly evolve new functions - in this case, the ability to degrade an antibiotic. Additionally, plasmids automatically amplify the number of copies of these new and improved resistance genes."

"These findings demonstrate a new role for plasmids in antibiotic resistance and evolutionary innovation, and they highlight the threat posed by plasmids to public health."

Antibiotic Resistance Pattern Stable Among Children in the US
Antibiotic resistance patterns in children have been stable over the last seven years in the United States.

Professor MacLean added, "The conventional view of plasmids is that they act as important vehicles that transfer resistance genes between bacteria. Our research shows a new role for plasmids in antibiotic resistance by demonstrating that plasmids drive the evolution of novel forms of antibiotic resistance. While this does not offer any solutions per se, it further highlights the importance of developing new methods for tackling plasmids. For example, it may be possible to develop new drugs that will block plasmid replication."

Source-Eurekalert